EGFR

Open Access
EGFR Levels in NSCLC Are Associated With Expression of SATB1 and EMT-promoting Factors
NATALIA GLATZEL-PLUCINSKA, ALEKSANDRA PIOTROWSKA, MATEUSZ OLBROMSKI, ADAM RZECHONEK, MARZENNA PODHORSKA-OKOLOW and PIOTR DZIEGIEL

Anticancer Research September 2025, 45 (9) 3639-3660; DOI: https://doi.org/10.21873/anticanres.17728
You have access
Magnolol Suppresses Osteosarcoma Progression via Apoptosis Induction and EGFR/AKT Pathway Inactivation in a U-2 OS Xenograft Model
CHI-HUAN LI, CHIA-JUNG TSAI, FEI-TING HSU, BING-RU PENG, MAO-CHI WENG, TSAI-LAN LIAO, HSIAO-CHIA WANG, CHING-YU HAN and JIANN-HWA CHEN

Anticancer Research July 2025, 45 (7) 2949-2961; DOI: https://doi.org/10.21873/anticanres.17662
You have access
Physalin F Inhibits Cell Viability and Induces Apoptosis in Non-small Cell Lung Cancer Cells
JHY-MING LI, KAO-TAI YANG and CHEAN-PING WU

Anticancer Research July 2025, 45 (7) 3031-3044; DOI: https://doi.org/10.21873/anticanres.17668
You have access
Real-world Data of the Lung Cancer Compact Panel™ in Non-small Cell Lung Cancer Using Tissue Samples
YOSHIHIKO TANIGUCHI, AKIHIRO TAMIYA, YUKARI KAMIYAMA, HITOSHI SUMITANI, YUKI IWAHASHI, AKIHIRO TSUKAGUCHI, EIJI SUGIMOTO, YUJI INAGAKI, KEIKO NAKAO, YOSHINOBU MATSUDA, MAIKO TAKEDA, TAKAHIKO KASAI, KYOICHI OKISHIO and SHIGEKI SHIMIZU

Anticancer Research April 2025, 45 (4) 1607-1615; DOI: https://doi.org/10.21873/anticanres.17542
You have access
EGFR Exon 19 Insertions: Do Patients Respond to Tyrosine Kinase Inhibitor Treatment?
GIUSEPPINA IMPROTA, GIULIA VITA, ALFREDO TARTARONE, GIOVANNI CALICE, LUDMILA CARMEN OMER and ANGELA ZUPA

Anticancer Research January 2025, 45 (1) 335-340; DOI: https://doi.org/10.21873/anticanres.17421
You have access
Impact of ABCG2 rs2231142(421C>A) Variant on the Clinical Outcomes of Patients With EGFR-mutated Non-small Cell Lung Cancer Treated With Gefitinib: A Comprehensive Meta-analysis
FRANCISCO CEZAR AQUINO DE MORAES, MARIA EDUARDA CAVALCANTI SOUZA, EMANUELE ROCHA DA SILVA, MICHELE KREUZ and ROMMEL MARIO RODRIGUEZ BURBANO

Anticancer Research December 2024, 44 (12) 5361-5370; DOI: https://doi.org/10.21873/anticanres.17363
You have access
Targeting EGFR Activation to Overcome Gemcitabine Resistance in Cholangiocarcinoma
SONEXAI KIDOIKHAMMOUAN, WORACHART LERT-ITTHIPORN, RAKSAWAN DEENONPOE, CHARUPONG SAENGBOONMEE, SUMALEE OBCHOEI, SOPIT WONGKHAM and WUNCHANA SEUBWAI

Anticancer Research December 2024, 44 (12) 5393-5404; DOI: https://doi.org/10.21873/anticanres.17366
You have access
Optimal Therapy for Postoperative Recurrence: Does Salvage Radiation Work for Locoregional Recurrence?
YURI TANIGUCHI, TAKAO SHIGENOBU, AKIKO HAYASHI, AYUMI HIRAHARA, KOTA ITO, HIROYUKI SHINOHARA, AYA SHIBA, YUKO HIGASHI, YUYA TABUCHI, TAKAHIRO SUZUKI, MASAHARU AGA, YUSUKE HAMAKAWA, KAZUHITO MIYAZAKI, MIZUKI SATO, YUKI MISUMI, YOKO AGEMI, YUKIKO NAKAMURA, TSUNEO SHIMOKAWA, KAZUMASA ODAGIRI, AKIRA YOSHIZU and HIROAKI OKAMOTO

Anticancer Research December 2024, 44 (12) 5541-5549; DOI: https://doi.org/10.21873/anticanres.17380
You have access
PD-L1 as a Biomarker for the Efficacy of Durvalumab in Stage III EGFR Mutant NSCLC
INSU KIM, SUN HA CHOI, SHIN YUP LEE, SEUNG SOO YOO, JI EUN PARK, KYEONG-CHEOL SHIN, JONG GEOL JANG, KYUNG SOO HONG, YONG SHIK KWON, SUN HYO PARK, KEUM-JU CHOI, CHI YOUNG JUNG, MI-HYUN KIM, SOO HAN KIM, HEE YUN SEOL, JEHUN KIM, JIN-HAN PARK, TAE HOON KIM, JUNG SEOP EOM and JUNE HONG AHN

Anticancer Research October 2024, 44 (10) 4505-4516; DOI: https://doi.org/10.21873/anticanres.17279
You have access
Functional Role of DUSP6 in the EGFR-mediated Progression of Head and Neck Squamous Cell Carcinoma
CHEN-HAN TAI, CHIH-CHUN WANG, YU-CHEN SHIH, YUN-JU CHEN, BEN-KUEN CHEN and LEI-CHIN CHEN

Anticancer Research June 2024, 44 (6) 2545-2554; DOI: https://doi.org/10.21873/anticanres.17060

Main menu

User menu

Search

EGFR

Pages